TrialRheumatology (Oxford, England)2019

Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis.

Isabel Mortimer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.